The current status and future directions of heavy charged particle therapy in medicine

AIP Conference Proceedings

Volumn 1099, Issue , 2009, Pages 410-425

  Levy, Richard P ^a   Blakely, Eleanor A ^b   Chu, William T ^b   Coutrakon, George B ^c   Hug, Eugen B ^d   Kraft, Gerhard ^e   Tsujii, Hirohiko ^f  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c NORTHERN ILLINOIS UNIVERSITY   (United States)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

^e Biophysics Group   (Germany)

^f NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

3d conformal; Heavy charged particle therapy; Light ions; RBE

Indexed keywords

EID: 65349092766     PISSN: 0094243X     EISSN: 15517616     Source Type: Conference Proceeding    
DOI: 10.1063/1.3120064     Document Type: Conference Paper

References (95)

1. H.B. Hewitt, Rationalizing radiotherapy: some historical aspects of the endeavor, Brit. J. Radiol. 46, 917-926 (1973).
2. M.A. Cleaves, Radium, with a preliminary note on radium rays in the treatment of cancer, Med. Rec. 64, 601-606 (1903).
3. C. Regaud and R. Ferroux, Discordance des effects de rayons X, d'une part dans le testicle, par le peau, d'autre parts dans le fractionment de la dose, Compt. Rend. Soc. Biol. 97, 431-434 (1927).
4. H. Coutard, Principles of X-ray therapy of malignant disease. Lancet 2, 1-12 (1934).
5. Perez and Brady's Principles and Practice of Radiation Oncology, edited by E. C. Halperin, C. A. Perez, L. W. Brady, D. E Wazer and C. Freeman, Lippincott, Williams & Wilkins: Philadelphia, 2008.
6. B. S. Teh, S. Y. Woo and E. B. Butler, Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology, The Oncologist 4, 433-442 (1999).
7. J. R. Castro, J. M. Quivey, J. T. Lyman, G. T. Chen, T. L. Phillips, C. A. Tobias and E. L. Alpen, Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory, Cancer 46, 633-641 (1980).
8. E. A. Blakely, "Current issues in low and high LET medical radiobiology" in Hadrontherapy in Oncology, edited by U. Amaldi and B. Larsson, Int. Congr. Series 1077: Elsevier Science, 1994, pp. 693-701.
9. E. A. Blakely, F. Q. H. Ngo, S. B. Curtis and C. A. Tobias, Heavy-ion radiobiology: cellular studies, Adv. Radiat. Biol. 11, 295-389 (1984).
10. G. Kraft G, Tumor therapy with heavy charged particles. Progr. Part. Nucl. Phys. 45, 473-544 (2000).
11. E. O. Lawrence and M. S. Livingston, The production of high speed protons without the use of high voltages. Phys. Rev. 38, 834 (1931).
12. R. R. Wilson, Radiological use of fast protons, Radiol. 47, 487-491 (1946).
13. C. A. Tobias, H. O. Anger and J. H. Lawrence, Radiological use of high-energy deuterons and alpha particles. Am. J. Roentgenol. Radium Therapy Nucl. Med. 67, 1-27 (1952).
14. R. P. Levy, J. I. Fabrikant, K. A. Frankel, M. H. Phillips and J. T. Lyman, Charged particle radiosurgery of the brain, Neurosurg. Clin. N. Am. 1, 955-990 (1990).
15. W. T. Chu, B. A. Ludewigt and T. R. Renner, Instrumentation for treatment of cancer using proton and light-ion beams. Rev. Sci. Instr. 64, 2055-2122 (1993).
16. J. H. Lawrence and J. A. Linfoot, Treatment of acromegaly, Cushing disease and Nelson syndrome, West. J. Med. 133, 197-202 (1980).
17. G. Harsh, J. S. Loeffler, A. Thornton, A. Smith, M. Bussiere and P. H. Chapman, Stereotactic proton radiosurgery, Neurosurg. Clin. N. Am. 10, 243-256 (1999).
18. G. K. Steinberg, J. I. Fabrikant, M. P. Marks, R. P. Levy, K. A. Frankel, M. H. Phillips, L. M. Shuer and G. D. Silverberg, Sterotactic heavy-charged-particle Bragg-peak radiation for intracranial vascular malformations, New Engl. J. Med. 323, 96-101 (1990).
19. E. B. Hug, L. N. Loredo, J. D. Slater, A. DeVries, R. I. Grove, R. A. Schaefer, A. E. Rosenberg and J. M. Slater, Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J. Neurosurg. 91, 432-439 (1999).
20. E. Gragoudas, W. Li, M. Goitein, A. M. Lane, J. E. Munzenrider and K. M. Egan, Evidence-based estimates of outcome in patients treated for intraocular melanoma, Arch. Ophthalmol. 120, 1665-1671 (2002).
21. R. Lin, J. D. Slater, L. T. Yonemoto, R. I. Grove, S. L. Teichman, D. K. Watt and J. M. Slater, Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy- dose-volume histogram analysis, Radiology 213, 489-494 (1999).
22. D. A. Bush, J. D. Slater, R. Bonnet, G. A. Cheek, R. D. Dunbar, M. Moyers and J. M. Slater, Proton-beam radiotherapy for early-stage lung cancer, Chest 116, 1313-1319 (1999).
23. D. A. Bush, D. J. Hillebrand, J. M. Slater and J. D. Slater, High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 127 (Suppl. 1), S189-S193 (2004).
24. J. D. Slater, C. J. Rossi, Jr., L. T. Yonemoto, D. A. Bush, B. R. Jabola, R. P. Levy, R. I. Grove, W. Preston
25. and J. M. Slater, Proton therapy for prostate cancer: the initial Loma Linda University experience, Int. J. Radiat. Oncol. Biol. Phys. 59, 348-352 (2004).
26. W. H. St. Clair, J. A. Adams, M. Bues, B. C. Fullerton, S. La Shell, H. M. Kooy, J. S. Loeffier andN. J. Tarbell, Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma, Int. J. Radiat. Oncol. Biol. Phys. 58, 727-734 (2004).
27. D. G. Kirsch and N. J. Tarbell, Conformal radiation therapy for childhood CNS tumors, The Oncologist 9(4), 442-450 (2004).
28. T. Haberer, W. Becher, D. Schardt and G. Kraft, Magnetic scanning system for heavy ion therapy, Nucl. Instr. and Meth. Phys. Res. A 330, 296-314 (1993).
29. H. Blattmann, G. Munkel, E. Pedroni, T. Böhringer, A. Coray, S. Lin, A. Lomax and B. Kaser-Hotz, "Conformal proton radiotherapy with a dynamic application technique at PSI," in Progress in Radio-Oncology V, edited by H. D. Kogelnik, Bologna: Monduzzi Editore, 1995, pp. 347-352.
30. M. Jermann, Hadron therapy patient statistics, Particle Therapy Cooperative Oncology Group, maintained at Paul Scherrer Institute website (2008).
31. J. R. Castro, W. M. Saunders, C. A. Tobias, G. T. Chen, S. Curtis, J. T. Lyman, J. M. Collier, S. Pitluck, K. A. Woodruff, E. A. Blakely, T. Tenforde, D. Char, T. L. Phillips and E. L. Alpen, Treatment of cancer with heavy charged particles, Int. J. Radiat. Oncol. Biol. Phys. 8,2191-2198 (1982).
32. C. A. Tobias, E. A. Blakely, E. L. Alpen, J. R. Castro, E. J. Ainsworth, S. B. Curtis, F. Q. Ngo, A. Rodriquez, R. J. Roots, T. Tenforde and T. C. Yang, Molecular and cellular radiobiology of heavy ions, Int J. Radiat. Oncol. Biol. Phys. 8, 2109-2120 (1982).
33. C. A. Tobias, The future of heavy-ion science in biology and medicine, Radiat. Res. 103, 1-33 (1985).
34. G. Kraft, Radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther. Onkol. 166, 10-13 (1990).
35. D. Schulz-Ertner and H. Tsujii, Particle radiation therapy using proton and heavier ion beams,J. Clin. Oncol. 25, 953-964 (2007).
36. R. P. Levy, PET-CT: evolving role in 3-D radiation therapy, Technol. Cancer Res. Treat. 5, 101-107 (2006).
37. E. Pedroni, "Pencil Beam Scanning," in Proton and Charged Particle Therapy, edited by T. F. DeLaney and H. M. Kooy, Lippincott, Williams & Wilkins: Philadelphia, 2008, pp. 40-49.
38. G. Kraft (private communication).
39. Y. Zheng, W. Newhauser, J. Fontenot, P. Taddei and R. Mohan, Monte Carlo study of neutron dose equivalent during passive scattering proton therapy, Phys. Med. Biol., 52, 4481-4496 (2007).
40. R. W. Schulte, W. J. Wicks, H. J. Meinass and W. J. Nethery, Vacuum-assisted fixation apparatus (US Patent #5730745) 1995.
41. B Ronson, L Yonemoto, C Rossi, J Slater and J Slater, Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer, Int. J. Radiat. Oncol. Biol. Phys. 64, 1367-1370 (2003).
42. M. Engelsman, A. Mazal and D. A. Jaffray, "Patient positioning and set-up verification for planning and treatment," in Proton and Charged Particle Therapy, edited by T. F. DeLaney and H. M. Kooy, Lippincott, Williams & Wilkins: Philadelphia, 2008, pp. 57-69.
43. H. Paganetti, H. Jiang, A. Trofimov, Monte Carlo simulation of proton beam scanning: modeling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry, Phys. Med. Biol. 50(5) 983-990 (2005).
44. C. Bert, S. O. Grozinger and E. Rietzel, Quantification of interplay effects of scanned particle beams and moving targets, Phys. Med. Biol, 53(9), 2253-2265 (2008).
45. J. M. Slater, J. O. Archambeau, D. W. Miller, M. I. Notarus, W. Preston and J. D. Slater, The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development, Int. J. Radiat. Oncol Biol Phys., 22, 383-389 (1992).
46. J. M. Lagniel, Status of the hadrontherapy projects in Europe, Particle Accelerator Conference, IEEE, pp. 127-131 (2007).
47. E. L. Alpen, W. Saunders, A. Chatterjee, J. Llacer, G. T. Chen and J. Scherer, A comparison of water equivalent thickness measurements: CT method vs. heavy ion beam technique. Brit. J. Radiol. 58, 542-548 (1985).
48. J Pawelke, W Enghardt, T Haberer, BG Hasch, R Hinz, M Kramer, E Lauckner, M Sobiella, In-beam PET imaging for the control of heavy-ion tumour therapy, Nuclear Science, IEEE Transactions, 44(4), 1492-1498 (1997)
49. W. Enghardt, J. Debus, T. Haberer, B. G. Hasch, R. Hinz, O. Jakel, M. Krämer, K. Lauckner, J. Pawelke and F. Ponisch, Positron emission tomography for quality assurance of cancer therapy with light ion beams, Nucl Phys. A, 654 (Suppl 1), 1047c-1050c (1999).
50. D. C. Weber, C. Ares, A. J. Lomax and J. M. Kurtz, Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview, Radiat. Oncol, (on line) 1, 22 (2006).
51. M. Amirul Islam, T. Yanagi, J. E. Mizoe, H. Mizuno and H. Tsujii, Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor, Radiat. Med. 26, 415-421 (2008).
52. R. Roots, W. Holley, A. Chaterjee, M. Irizarry and G. Kraft, The formation of strand breaks in DNA after high-LET irradiation: a comparison of data from in vitro and cellular systems, Int. J. Radiat. Biol. 58(1), 55-69 (1990).
53. R. Hirayama, Y. Furusawa, T. Fukawa and K. Ando, Repair kinetics of DNA-DSB induced by X-rays or carbon ions under oxic and hypoxic conditions, J. Radiat. Res. (Tokyo) 46(3), 325-332 (2005).
54. M. Hada and A. G. Georgakilas, Formation of clustered DNA damage after high-LET irradiation: a review, J. Radiat. Res. 49, 203-210 (2008).
55. S. Sawada and K. Komatsu, Cell cycle and LET dependence for radiation-induced mutation: a possible mechanism for reversed dose-rate effect, J. Radiat. Res. (Tokyo) 40 (Suppl), 45-52 (1999).
56. M. Scholz, G. Kraft, Calculation of heavy ion inactivation probabilities based on track structure, X- ray sensitivity and target size. Radiat. Prot. Dosim. 52(1-4), 29-34 (1994).
57. E. A. Blakely, P. Y. Chang and L. Lommel, Cell-cycle- dependent recovery from heavy-ion damage in Gl phase cells, Radiat. Res. 8 (Suppl), S145-S157 (1985).
58. C. Lucke-Huhle, E. A. Blakely, F. Q. H. Ngo, P. Y. Chang and C. A. Tobias, Drastic G2 arrest in mammalian cells after irradiation with heavy-ion beams, Int. J. Radiat. Res. 37, 483-492 (1980).
59. K. Ando, S. Koike, A. Uzawa, N. Takai, T. Fukawa, Y. Furusawa, M. Hoki and R. Hirayama, Repair of skin damage during fractionated irradiation with gamma rays and low-LET carbon ions,J. Radiat. Res (Tokyo) 47(2), 167-174 (2006).
60. E. A. Blakely and A. Kronenberg, Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness, Radiat. Res., 150 (Suppl), S126-S145 (1998).
61. L. S. Goldstein, T. S. Phillips and G. Y. Ross, Enhancement by fractionation of biological peak to plateau relative biological effectiveness ratios for heavy ions, Int. J. Radiat. Oncol. Biol. Phys. 4(11-12), 1033-1037 (1978).
62. L. S. Goldstein, T. S. Phillips, K. K. Fu, G. Y. Ross and L. J. Kane, Biological effects of accelerated heavy ions I. Single doses in normal tissue tumors and cells in vitro, Radiat. Res. 86(3), 529-541 (1981).
63. L. S. Goldstein, T. S. Phillips and G. Y. Ross, Biological effects of accelerated heavy ions II. Fractionated irradiation of intestinal crypt cells, Radiat. Res. 86(3), 542-558 (1981).
64. J. T. Leith, E. J. Ainsworth and E. L. Alpen, Heavy-ion radiobiology: normal tissue studies, Adv. Radiat. Biol. 10, 191-236 (1983).
65. J. Gueulette, M. Octave-Prignot, B.-M. De Costera, A. Wambersie and V. Grégoire, Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy, Radiother. Oncol. 73 (Suppl 2), S148-S154 (2004).
66. M. Raju, Heavy Particle Radiotherapy, Academic Press: New York, 1980.
67. H. Tsujii, H. Ishikawa, T. Yanagi, N. Hirasawa, T. Kamada, J. E. Mizoe, T. Kanai, H. Tsuji and Y. Ohnishi, Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a phase I/II dose-escalation study, Int. J. Radiat. Oncol. Biol. Phys. 67(3), 857-862 (2007).
68. H. Tsuji, T. Yanagi, H. Ishikawa, T. Kamada, J. Mizoe, T. Kanai, S. Morita, H. Tsujii, S. Yamada, S. Kandatsu, K. Yoshikawa and T. Obata, Hypofractionated radiotherapy with carbon ion beams for prostate cancer, Int. J. Radiat. Oncol. Biol. Phys. 63, 1153-1160 (2005).
69. H. Tsujii, T. Kamada, M. Baba, H. Tsuji, H. Kato, S. Kato, S. Yamada, S. Yasuda, T. Yanagi, H. Kato, R. Hara, N. Yamamoto and J. Mizoe, Clinical advantages of carbon-ion radiotherapy, New J. Phys. 10, 1-16 (2008).
70. H. Tsujii, J. E. Mizoe, T. Kamada, M. Baba, S. Kato, H. Kato, H. Tsuji, S. Yamada, S. Yasuda, T. Ohno, T. Yanagi, A. Hasegawa, T. Sugawara, H. Ezawa, S. Kandatsu, K. Yoshikawa, R. Kishimato and T. Miyamato, Overview of clinical experiences on carbon ion radiotherapy at NIRS, Radiother. Oncol. 73 (Suppl 2), 541-549 (2004).
71. T. Miyamoto, M. Baba, T. Sugane, M. Nakajima, T. Yashiro, K. Kagei, N. Hirasawa, T. Sugawara, N. Yamamoto, M. Koto, H. Ezawa, K. Kadono, H. Tsujii, J. Mizoe, K. Yoshikawa, S. Kandatsu and T. Fujisawa, Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week, J. Thorac. Oncol. 2(10), 916-926 (2007).
72. S. Kato, T. Ohno, H. Tsujii, T. Nakano, J. E. Mizoe, T. Kamada, T. Miyamoto, H. Tsuji, H. Kato, S. Yamada, S. Kandatsu, K. Yoshikawa, H. Ezawa and M. Suzuki, Dose escalation study of carbon ion radiation therapy for locally advanced carcinoma of the uterine cervix, Int. J. Radiat. Oncol. Biol. Phys. 65(2), 388-397 (2006).
73. H. Hofman-Hüther, M. Scholz, M. Rave-Frank and P. Virsik-Köpp, Induction of reproductive cell death and chromosome aberrations in radioresistant tumour cells by carbon ions, Int. J. Radiat. Biol. 80(6), 423-435 (2004).
74. N. Hamada, T. Hara, M. Omura-Minamisawa, T. Funayama, T. Sakashita, S. Sora, Y. Yokota, T. Nakano and Y. Kobayashi, Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bel - 2, Radiother. Oncol, (in press) (2008).
75. W. K. Weyrather and J. Debus, Particle beams for cancer therapy, Clin. Oncol. 15(1), S23-S28 (2003).
76. Th. Elsässer and M. Scholz, Improvement of the local effect model (LEM) - implications of clustered DNA damage, Radiat. Protect. Dosim. 122(1-4) 475-477 (2006).
77. Th. Elsässer, M. Krämer and M. Scholz, Accuracy of the Local Effect Model for the prediction of biologic effects of carbon ion beams in-vitro and in-vivo, Int. J. Radiat. Oncol. Biol. Phys. 71(3), 866-872 (2008).
78. M. Kramer, O. Jäkel, T. Haberer, G. Kraft, D. Schardt and U. Weber, Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization, Phys. Med. Biol. 45, 3299-3317 (2000).
79. Y. Kase, T. Kanai, N. Matsufuji, Y. Furusawa, Th. Elsasser and M. Scholz, Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation, Phys. Med. Biol. 53, 37-59 (2008).
80. M. Kellerer and H. H. Rossi, A generalized formulation of dual radiation action, Radiat. Res. 75, 471-488 (1978).
81. R. Katz, B. Anderson, M. Homayoonfar and S. C. Sharma, Inactivation of cells by heavy ion bombardment, Rad. Res. 47, 402-425 (1971).
82. N. Matsufuji, T. Kanai, N. Kanematsu, T. Miyamoto, M. Baba, T. Kamada, H. Kato, S. Yamada, J. E. Mizoe, H. Tsujii, Specification of carbon ion dose at the National Institute of Radiological Sciences (NIRS,),J. Radiat. Res. 48 (Suppl) A81-A86 (2007).
83. O. Jäkel, D. Schulz-Erner and J. Debus, Specifying carbon ion doses for radiotherapy: the Heidelberg approach, J Radiat. Res. 48 (Suppl) A87-A95 (2007).
84. J.E. Munzenrider, N.J. Liebsch, Proton therapy for tumors of the skull base. Strahlenther. Onkol. 175 (Suppl 2), 57-63 (1999).
85. A. L. Zietman, M. L. DeSilvio, J. D. Slater, C. J. Rossi Jr, D. W. Miller, J. A. Adams and W. U. Shipley, Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial, J.A.M.A. 294(10), 1233-1239 (2005). (Erratum in: J.A.M.A. 299(8), 898-899 (2008).)
86. J. E. Mizoe, H. Tsujii, T. Kamada, Y. Matsuoka, H. Tsuji, Y. Osaka, A. Hasegawa, N. Yamamoto, S. Ebihara and A. Konno, Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer, Int. J. Radiat. Oncol. Biol. Phys. 60, 358-364 (2004).
87. D. Schulz-Ertner, T. Haberer, M. Scholz, C. Thifmann, F. Wenz, O. Jäkel, G. Kraft, M. Wannenmacher and J. Debus, Acute radiation-induced toxicity of heavy ion radiotherapy delivered with intensity modulated pencil beam scanning in patients with base of skull tumors, Radiother. Oncol. 64, 189-195 (2002).
88. H. Kato, H. Tsujii, T. Miyamoto, J. Mizoe, T. Kamada and H. Tsui, Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis, Int. J. Radiat. Oncol. Biol. Phys. 59, 1468-1476 (2004).
89. R. Imai, T. Kamada, H. Tsuji, T. Yanagi, M. Baba, T. Miyamoto, S. Kato, S. Kandatsu, J. Mizoe, H. Tsujii and S. Tatezaki, Carbon ion radiotherapy for unresectable sacral chordomas, Clin. Cancer Res. 10, 5741-5746 (2004).
90. O. Jäkel, D. Schulz-Ertner, C. P. Karger, P. Heeg and J. Debus, Experience with carbon ion radiotherapy at GSI Nucl. Inst. andMeth. Phys. Res. B, 241, 717-720 (2005).
91. J. B. Flanz, What's new in particle therapy accelerator technology? Nucl. Inst. Meth. and Phys. Res. B, 261, 768-772 (2007).
92. K. Hiramoto, M. Umezawa, K. Saito, S. Tootake, H. Nishiuchi, S. Hara, M. Tanaka, K. Matsuda, H. Sakurabata and K. Moriyama, The synchrotron and its related technology for ion beam therapy, Nucl. Inst. Meth. and Phys. Res. B, 261, 786-790 (2007).
93. G. J. Caporaso, S. Sampayan, Y. J. Chen, J. Harris, S. Hawkins, C. Holmes, M. Krogh, S. Nelson, W. Nunnally, A. Paul, B. Poole, M. Rhodes, D. Sanders, K Selenes, J. Sullivan, L. Wang and J. Watson, Compact accelerator concept for proton therapy, Nucl. Inst. Meth and Phys. Res. B, 261, 777-781 (2007).
94. C. Joshi, Plasma accelerators, Scientific American, 294, 41-47 (2006).
95. W. Luo, E. Fourkal, J. Li and C. M. Ma, Particle selection and beam collimation system for laser-accelerated proton beam therapy, Med. Phys. 32 (3), 794-806 (2005).